GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Medexus Pharmaceuticals Inc (TSX:MDP) » Definitions » Total Equity

Medexus Pharmaceuticals (TSX:MDP) Total Equity : C$39.7 Mil (As of Dec. 2023)


View and export this data going back to 2012. Start your Free Trial

What is Medexus Pharmaceuticals Total Equity?

Medexus Pharmaceuticals's total equity for the quarter that ended in Dec. 2023 was C$39.7 Mil.

This is Residual interest, including minority interest, that remains in the assets of the enterprise after deducting its liabilities. Equity is increased by owners’ investments and by comprehensive income, and it is reduced by distributions to the owners.

Medexus Pharmaceuticals Total Equity Historical Data

The historical data trend for Medexus Pharmaceuticals's Total Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Medexus Pharmaceuticals Total Equity Chart

Medexus Pharmaceuticals Annual Data
Trend Dec13 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
Total Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only 37.44 33.89 22.65 22.53 30.72

Medexus Pharmaceuticals Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Total Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 20.96 30.72 30.20 29.42 39.66

Medexus Pharmaceuticals Total Equity Calculation

Total Equity and Total Liabilities are the two components for Total Assets.

Medexus Pharmaceuticals's Total Equity for the fiscal year that ended in Mar. 2023 is calculated as

Total Equity=Total Assets(Q: Mar. 2023 )-Total Liabilities(Q: Mar. 2023 )
=220.746-190.031
=30.7

Medexus Pharmaceuticals's Total Equity for the quarter that ended in Dec. 2023 is calculated as

Total Equity=Total Assets(Q: Dec. 2023 )-Total Liabilities(Q: Dec. 2023 )
=215.162-175.501
=39.7

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Medexus Pharmaceuticals Total Equity Related Terms

Thank you for viewing the detailed overview of Medexus Pharmaceuticals's Total Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Medexus Pharmaceuticals (TSX:MDP) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Medexus Pharmaceuticals Inc (TSX:MDP) » Definitions » Total Equity
Comparable Companies
TSX:CWEB XCNQ:HUGE TSXV:DB XCNQ:MMEN XCNQ:CXXI TSXV:ZYUS TSX:AVNT XCNQ:ACRG.A.U XCNQ:GDNS TSXV:LSL ZTS XTER:MRK TSE:4502 LSE:HLN NSE:SUNPHARMA TSE:4523 TSE:4507 SZSE:000538 XSWX:SDZ HKSE:03692
Traded in Other Exchanges
MEDXF:USA P731:Germany
Address
35 Nixon Road, Suite 1, Bolton, ON, CAN, L7E 1K1
Website
https://www.medexus.com
Medexus Pharmaceuticals Inc is an innovative and rare disease pharmaceutical company with a strong North American commercial platform and a portfolio of proven best-in-class products. The company's focus is on the therapeutic areas of hematology, auto-immune diseases, and allergy.
Executives
Benoit Gravel Director